ArticleAnnals of translational medicine2016
C-WORTHY: the beginning of the rise of elbasvir and grazoprevir for the treatment of hepatitis C genotype 1 mono and HIV co-infected patients.
Dost Sarpel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.